CE MArk

 
The Medennium MPL has a CE Mark and is available for implantation by eye surgeons throughout the EU as well as other countries that accept the CE Mark.

surgeons

 

Well over 1,300 surgeons from around the world have been trained in courses taught by Dimitrii Dementiev MD and sponsored by Medennium, Inc.

A Phakic IOL You Can Trust

The MPL is the NEW next generation of the PRL which was so successful in surgically treating Myopia and Hyperopia. 

 

READ MORE

 MPL STUDY GROUP

The haptics of the MPL are thinner than they are on the PRL making it much easier to insert either by Injector or Forceps.  Also the Myopic MPL [Model 100 & 101] (lower left) comes in different lengths to accommodate different sized eyes lessening the possibility of decentration and rotation.  The Hyperopic MPL [Model 200] (below right) comes in a smaller size to accommodate these smaller eyes.    

FORUM FOR LEARNING, COLLABORATION, and discussion regarding the Posterior Phakic IOL
by Medennium

latest INFO "5% ICLs develop surgical cataract"

American Journal of Ophthalmology Implantation of Posterior Chamber Phakic Intraocular Lens for myopia March 2014 AJO In this retrospective observational case series, Igarashi et al. assessed the long-term clinical outcomes of posterior chamber collamer lens implantation for moderate to high myopia. They found that during the 8-year study period, implantation was successful in terms of safety, efficacy, predictability, and stability, suggesting that it is a viable alternative to corneal refractive procedures. The authors evaluated 41 eyes of 41 patients with myopic refractive errors of –4.00 to –15.25 D who underwent implantation of the a collamer ICL lens. The safety and efficacy indices were 1.13 ± 0.27 and 0.83 ± 0.36, respectively. At 8 years, 68% of eyes were within 0.5 D of the targeted correction, and 85% were within 1.0 D. Manifest refraction changes of –0.32 ± 0.73 D occurred between 1 month and 8 years. The mean endothelial cell loss from preoperative levels was 6.2% at 8 years. Two eyes (5%) developed clinically significant symptomatic cataract during the follow-up period. Simultaneous extraction of the collamer lens and phacoemulsification with IOL implantation were successfully performed in these cases.